A new asthma drug, Airsupra, combines the short-acting β2-adrenergic agonist albuterol with the corticosteroid budesonide to treat acute asthma attacks.Patients should not stop their asthma maintenance therapy when albuterol-budesonide is prescribed.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/01.NAJ.0000933924.55473.4e | DOI Listing |
Publication Analysis
Top Keywords
asthma drug
8
combination asthma
4
drug asthma
4
drug airsupra
4
airsupra combines
4
combines short-acting
4
short-acting β2-adrenergic
4
β2-adrenergic agonist
4
agonist albuterol
4
albuterol corticosteroid
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!